Hony Capital Completes $570M Partial Exit From CSPC Pharma

Login to View

Beijing-headquartered Chinese private equity firm Hony Capital has completed a partial exit from Hong Kong-listed Chinese generic drugs maker CSPC Pharmaceutical Group, selling 705.88 million shares for a total proceeds of HK$4.41 billion (US$570 million), according to a regulatory filing.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in

Join China Money Network for $89 a month